21 CFR § 341.18
Expectorant active ingredient
June 25, 2020
The active ingredient of the product is guaifenesin when used within the dosage limits established in §341.78(d).
[54 FR 8509, Feb. 28, 1989]
The active ingredient of the product is guaifenesin when used within the dosage limits established in §341.78(d).
[54 FR 8509, Feb. 28, 1989]